Regulation Importance In Pharma Industry

213
2802

Today, Regulatory Affairs is a dynamic business unit that works with the goal of bringing products with a commercially viable label to market with the least amount of time and expense. Given the increasing global competitiveness of pharmaceutical companies, the key to success lies in obtaining timely marketing approval from Regulatory Affairs for the region where the drug is to be sold. Various government agencies are involved in the regulation of drugs in their market. Some of them include:

USFDA-US, EMEA-Europe, TGA-Australia and MHRA-UK and TPD-CANADA.

Patent expirations, tight healthcare budgets and a tighter regulatory climate are major challenges for the pharmaceutical industry. Many companies are in a race to place their new products on the global market and to gain market share and increase their profits.

In such scenario, a small delay in entering the market means a huge loss in terms of market share and revenue generated. The keys to success for pharmaceutical companies lie in obtaining timely marketing authorizations from regulators. So, to get timely marketing approval, companies can either beef up their regulatory department or outsource it to a regulatory affairs consultancy.

Current regulatory scenario

The main legislation governing clinical trials is the Drugs and Cosmetics Act, 1940 and the management authority is the Drugs Controller General of India (DCGI). Annex Y of the Medicines and Cosmetics Rules, 1945 sets out the regulations for the import and manufacture of new medicines for sale and for clinical trials in India. In addition, the Indian Council for Medical Research (ICMR) has issued ethical guidelines for biomedical research involving human participants and the Central Drugs Standard Control Organization has formulated guidelines for good clinical practice (GCP guidelines) in accordance with published international guidelines. by the World Health Organization and International Harmonization Committee (ICHGCP), which provides operational guidelines for ethical and scientific standards for the design of a clinical trial protocol, including including driving, check-in, safety and reporting procedures. It is mandatory for any organization undertaking a clinical trial in India to strictly adhere to these guidelines.

It cannot be denied that clinical trials are the foundation for the introduction of better drugs, medical practices and devices. The fact that it involves law and ethics makes it a challenge for those who craft the legal provisions. The Department of Health and DCGI should leave no room for complacency when it comes to human trials and ensure that the gaps are filled by ensuring consistency and lifting of the inconsistency. 39; ambiguity of existing regulations. However, the law only has the power to regulate, supervise and ensure the protection of subjects to a certain extent.

With the evolution of global regulatory standards, outsourcing the work of regulatory affairs appears to be a more cost effective option in terms of both time and money. Maintaining a great Regulatory Affairs department can be very costly, and the breadth of knowledge may be limited to some aspects. On the other hand, a Regulatory Affairs Consultant keeps updating with current regulations and has vital experience in the field to speed up the approval process.

Pharmaceutical regulatory affairs concern both investigational new drugs (INDs) and generics. Well-established regulatory firms can provide services in the following ways:

Compilation and formulation of a great regulatory application for the submission of the two APIs in different countries, commonly known as dossiers.

Expertise in regulatory and scientific knowledge.

Expertise and support in local regulatory authority.

Expert solutions to requests from the FDA and other regulatory agencies. Access to scientific and technical resources.

Formulation and implementation of regulatory strategies at the global level.

The regulatory affairs unit of the pharmaceutical industry serves as the backbone of its survival. It concerns the implications for public health, standard setting and intellectual property rights in drug development, the public accountability of regulatory agencies, the procedures used by pharmaceutical companies for regulatory compliance, and discusses the complex web of regulatory requirements, enforcement processes, and quality control. issues influencing the pharmaceutical industry.

On the other hand, a regulatory firm will speed up the submission process in tandem with the active participation of the client (the party hiring the regulatory firm). Once established, the service offered by a regulatory affairs professional can help the business save time and money. Therefore, an appropriate selection of regulatory professionals is very important. Consultants should have experience in preparing and submitting regulatory documents and in-depth knowledge to obtain approval of various drugs, and be able to formulate regulatory strategies and implement them. Professional references, documents prepared, approvals obtained and articles published by them can be better sources to assess their experience.


Comments are closed.